Cole Trapnell

ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin.

Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA.

LGC-Group LLC provides financial advisory services. The private company is based in Miami, FL.

Axion BioSystems, Inc. develops life science instrumentation and medical diagnostic equipment. The firms products include, such as MEA systems, MEA plates, AxIS software, and Lumos. The company was founded by Thomas J. O'Brien, Mark G. Allen, Swaminathan Rajaraman, Edgar Brown, Stephen P. DeWeerth and James D. Ross in May 2008 and is headquartered in Atlanta, GA.

Omniome, Inc. provides biotechnical research services. The firm's biosensors can be adopted for mobile diagnostics and health monitoring applications. The company was founded by Kandaswamy Vijayan in 2013 and is headquartered in San Diego, CA.

Nordic Capital Ltd. (Nordic Capital) is a private equity subsidiary of Triona Holding SA founded in 1989 by Robert Andreen and Morgan Olsson. The firm is headquartered in St Hellier, New Jersey.

LGC Ltd. engages in the provision of scientific tool and solutions. It offers genomic analysis tools, drug development solutions, national laboratory, and health research program management. The company was founded in 1842 and is headquartered in Middlesex, the United Kingdom.

Life Technologies Clinical Services Lab, Inc. offers clinically guided personal genetic testing services for customers. The firm develops and commercializes genetics-based products and services to enhance individual health and wellness; and educates and empowers individuals and their physicians by providing personalized genetic insights about disease risk and medication response to catalyze behavior change and inform clinical decision-making. The company was founded by David B. Agus and Dietrich A. Stephan in 2006 and is headquartered in Foster City, CA.

Eurofins Genomics LLC engages in the provision of genomic products and services. It offers deoxyribonucleic acid (DNA) sequencing, gene synthesis, and bioinformatics services for academic and industrial research. The company was founded in 1990 and is headquartered in Louisville, KY.

Exploit Technologies Pte Ltd. operates as intellectual property portfolio company. It is a technology company which transfer arm of the Agency for Science, Technology and Research. Exploit Technologies and is headquartered in Singapore.

The Binding Site Group Ltd. engages in the development of medical equipment. It provides specialist diagnostic products to clinicians and laboratory professionals worldwide. Its products include freelite and hevylite; analysers and software; immunoassays; and manufacturing components. The company was founded by Jo Bradwell in 1983 and is headquartered in Birmingham, the United Kingdom.

Hytest Oy manufactures biological products. It operates as producer of monoclonal antibodies and antigens for the diagnostic industry. The company was founded in 1994 and is headquartered in Turku, Finland.

BlueTalon, Inc. provides unmatched data entitlement solutions. It offers single-click data collaboration and data unification technology. The company was founded by Pratik Verma in 2013 and is headquartered in Sunnyvale, CA.

Verana Health, Inc. engages in the development of software solutions for remote patient monitoring and data analytics. It focuses on bridging the gap between healthcare providers and patients with mobile tests. The company was founded by Mark S. Blumenkranz and Daniel V. Palanker in 2008 and is headquartered in San Francisco, CA.

Insilixa, Inc. develops molecular diagnostic platform. It offers CMOS biochips for microarray technology, qPCR, and DNA sequencing. The company was founded by Arun Manickam and Arjang Hassibi in 2012 and is headquartered in Sunnyvale, CA.

bng0 LLC provides investment services. The firm invests in Editas Medicine and long-term horizon. The company was founded by Boris Nikolic and is headquartered in Seattle, WA.

Bluebee Holding BV engages in the development of a private cloud-based accelerated genomics platform. It supports cross-functional teams of life science researchers and clinicians by effectively centralizing and managing their genomics data processes and storage needs. The company was founded in 2011 by Vlad-Mihai Sima, Koen Bertls, Luk Wayne, and Zaid Al-Ars and is headquartered in Rijswijk, the Netherlands.

Summa Equity AB (Summa Equity) is a private equity firm founded in 2016 by Jenny Keisu, Reynir Kjær Indahl and Johannes Hidle Lien. The firm is headquartered in Stockholm, Sweden.

Biomatics Capital Management Co LLC (Biomatics Capital) is a venture capital firm founded in 2016 by Boris Nikolic and Julie Sunderland. The firm is headquartered in Seattle, Washington.

Aquatrove Biosciences, Inc. engages in the discovery, research and development in human reproductive health and fertility. It develops over-the-counter products to address issues relating to human fertility and conception. The company was founded by Vibha Gupta, Boris Nikolic and Vineet Gupta in 2005 and is headquartered in Chicago, IL.

eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.

Phase Genomics, Inc. operates as a biopharmaceutical company. It products include proximeta Hi-C metagenomics deconvolution and proximo Hi-C genome scaffolding. The company was founded by Ivan Liachko and Shawn Sullivan in February 2015 and is headquartered in Seattle, WA.

Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming.

Slingshot Biosciences, Inc. is a life sciences company that develops synthetic cells for various applications in diagnostics and therapeutics. The company is based in Emeryville, CA. The company utilizes advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf solution for cell-like reagents that are stable, low-cost, and targeted towards a range of indications and markets. Slingshot Biosciences focuses on developing cutting-edge tools for fluorescence imaging to revolutionize how scientists explore and understand the intricate mechanisms of life. The company is committed to empowering researchers with exceptional products that enable groundbreaking discoveries and shape the future of bioscience. The company was founded in 2012 by Jeffrey Kim, who has been the CEO since 2012.

One BioMed Pte Ltd. provides integrated molecular diagnostics services. The firm develops portable point-of-care diagnostic system, where doctors and patients will no longer have to wait for days for samples to be sent to a central laboratory for tests. The company was founded by Mi-Kyoung Park in 2015 and is headquartered in Singapore.

Biopath Ventures (Biopath Ventures) is a venture capital firm founded in 2018 by Joseph Jeong. The firm is headquartered in Millbrae, California.

Encodia, Inc. engages in the research and development of protein analysis tools. The company was founded by Mark S. Chee, Michael Weiner, and Kevin Gunderson and is headquartered in San Diego, CA.

M51 Topco, Inc., through its subsidiary Velsera, is a company that connects healthcare and life sciences to enable precision medicine. The company is based in Boston, MA, and has subsidiaries in the United States and Belgium. The company aims to create a continuous flow of knowledge between researchers, scientists, and clinicians worldwide to improve human health. Velsera's focus is on creating insights that can radically improve human health. Gavin Nichols has been the CEO of the company since 2022.